← All State Street CORP filings

State Street CORP Schedule 13G passive stakes

NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.6% Stake in Brandywine Realty
State Street Corporation has reported a 4.6% beneficial ownership stake in Brandywine Realty Trust's common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in BioCryst Pharma
State Street Corporation has reported a 5.3% beneficial ownership stake in BioCryst Pharmaceuticals Inc., holding over 11 million common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in Beam Therapeutics
State Street Corporation has reported a 5.2% beneficial ownership stake in Beam Therapeutics Inc., holding over 5.2 million common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.8% Stake in Astronics Corp
State Street Corporation has filed a Schedule 13G, reporting a 5.8% beneficial ownership stake in Astronics Corp common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Archer Aviation
State Street Corporation has reported a 5% beneficial ownership stake in Archer Aviation Inc., holding over 32 million shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.8% Stake in American Battery Tech
State Street Corporation has reported a 5.8% beneficial ownership stake in American Battery Technology Co, holding 7,529,560 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in Akebia Therapeutics
State Street Corporation has reported a 5.2% beneficial ownership stake in Akebia Therapeutics Inc., holding 13,687,561 common shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in Agios Pharma
State Street Corporation has reported a 5.3% beneficial ownership stake in Agios Pharmaceuticals Inc., holding 3,108,145 common shares as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in A O Smith Corp
State Street Corporation has reported a 5.2% beneficial ownership stake in A O Smith Corp common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 1.6% Stake in 908 Devices Inc.
State Street Corporation and its subsidiary SSGA Funds Management, Inc. have reported beneficial ownership of 908 Devices Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 7.5% Stake in Omnicom Group
State Street Corporation and its affiliates have reported a 7.5% beneficial ownership stake in Omnicom Group Inc. common stock as of December 31, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Boosts Omnicom Stake to 13.8%
State Street Corporation and its affiliates have reported a significant increase in their beneficial ownership of Omnicom Group Inc. common stock, now holding 13.8% of the class.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Stake in Williams-Sonoma
State Street Corporation has reported a 5% beneficial ownership stake in Williams-Sonoma Inc., primarily through shared voting and dispositive power.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Verizon
State Street Corporation has reported a 5.1% beneficial ownership stake in Verizon Communications Inc., holding over 215 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.6% Stake in Vericel Corp
State Street Corporation has reported a 5.6% beneficial ownership stake in Vericel Corp, holding 2,807,242 shares of common stock as of September 30, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.3% Stake in Veracyte Inc.
State Street Corporation has reported a 5.3% beneficial ownership stake in Veracyte Inc., holding 4,199,674 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.9% Stake in Valley National Bancorp
State Street Corporation has reported a beneficial ownership of 4.9% in Valley National Bancorp's common stock, totaling 27,587,857 shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 4.1% Stake in Uranium Energy Corp
State Street Corporation has reported a 4.1% beneficial ownership stake in Uranium Energy Corp, holding 19,011,654 common shares as of September 30, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Twist Bioscience
State Street Corporation has reported a 5.1% beneficial ownership stake in Twist Bioscience Corp. as of September 30, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 8.4% Stake in Tompkins Financial
State Street Corporation and its affiliates have reported a significant 8.4% beneficial ownership stake in Tompkins Financial Corp common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.5% Stake in Williams Cos.
State Street Corporation has reported a 5.5% beneficial ownership stake in Williams Companies Inc., holding over 66 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 8.2% Stake in The Trade Desk
State Street Corporation and its subsidiary SSGA Funds Management, Inc. have disclosed an 8.2% beneficial ownership stake in The Trade Desk Inc. common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Boosts Stake in Interpublic Group to 8.8%
State Street Corporation and its subsidiary SSGA Funds Management, Inc. have disclosed an aggregate beneficial ownership of 8.8% in Interpublic Group of Cos Inc. common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in TG Therapeutics
State Street Corporation has reported a 5.1% beneficial ownership stake in TG Therapeutics Inc., totaling 8,100,619 shares of common stock.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in Textron Inc.
State Street Corporation has reported a 5.2% beneficial ownership stake in Textron Inc.'s common stock, primarily through shared voting and dispositive powers.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Texas Pacific Land
State Street Corporation has reported a 5.1% beneficial ownership stake in Texas Pacific Land Corp, holding over 1.1 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.1% Stake in Synchrony Financial
State Street Corporation has reported a 5.1% beneficial ownership stake in Synchrony Financial, totaling over 19 million shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.2% Stake in Seacoast Banking
State Street Corporation has reported a 5.2% beneficial ownership stake in Seacoast Banking Corp of Florida, holding 4,545,768 common shares.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5.4% Stake in Sarepta Therapeutics
State Street Corporation has reported a 5.4% beneficial ownership stake in Sarepta Therapeutics Inc. common stock as of September 30, 2025.
NYSE
STT
State Street CORP
SCHEDULE: State Street Discloses 5% Passive Stake in Royal Gold Inc.
State Street Corporation has reported a 5% passive beneficial ownership stake in Royal Gold Inc., holding 3,321,868 shares of common stock.